CACHD1 and metabolic dysfunction-associated steatohepatitis: Although no CACHD1+ foci in the mouse liver was earlier found in NASH animal models, a marked increase in their number and area was here evident, demonstrating that this could be an early event in STAM mice NASH hepatocarcinogenesis.